Cargando…

Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas

Adenocarcinoma is the most common type of lung cancer. Epithelial-mesenchymal transition (EMT) is required for tumor invasion/metastasis and the components that control this process are potential therapeutic targets. This study we examined the role of Gli in lung adenocarcinoma and whether its activ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hui, Yue, Dongsheng, Jin, Joy Q., Woodard, Gavitt A., Tolani, Bhairavi, Luh, Thomas M., Giroux-Leprieur, Etienne, Mo, Minli, Chen, Zhao, Che, Juanjuan, Zhang, Zhenfa, Zhou, Yong, Wang, Lei, Hao, Xishan, Jablons, David, Wang, Changli, He, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348330/ https://www.ncbi.nlm.nih.gov/pubmed/27533453 http://dx.doi.org/10.18632/oncotarget.11246

Ejemplares similares

EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas
por: Yue, Dongsheng, et al.
Publicado: (2015)

Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas
por: Yue, Dongsheng, et al.
Publicado: (2014)

Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma
por: Li, Hui, et al.
Publicado: (2013)

Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog
por: Tolani, Bhairavi, et al.
Publicado: (2018)

Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer
por: Giroux Leprieur, Etienne, et al.
Publicado: (2017)

Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma
por: Wang, Lei, et al.
Publicado: (2017)

Old Sonic Hedgehog, new tricks: a new paradigm in thoracic malignancies
por: Giroux Leprieur, Etienne, et al.
Publicado: (2018)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
por: Wang, Changli, et al.
Publicado: (2012)

Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report
por: Magdelaine, Pierre, et al.
Publicado: (2022)

2460: Change in duration of postoperative antibiotic prophylaxis in esophagectomy patients: Outcomes in a single academic institution
por: Wang, Sue, et al.
Publicado: (2018)

Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance
por: Giroux-Leprieur, Etienne, et al.
Publicado: (2018)

Successful pulmonary arterial embolization followed by curative surgery for a lepidic predominant lung adenocarcinoma with severe hypoxemia
por: Sebane, Louise, et al.
Publicado: (2018)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications
por: Tolani, Bhairavi, et al.
Publicado: (2018)

Targeting Gli Transcription Activation by Small Molecule Suppresses Tumor Growth
por: Bosco-Clément, Geneviève, et al.
Publicado: (2013)

Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay
por: Gupta, Alexander R, et al.
Publicado: (2021)

Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma
por: Jiang, Long, et al.
Publicado: (2019)

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring
por: Chang, Yi, et al.
Publicado: (2017)

Gli1 regulates stemness characteristics in gastric adenocarcinoma
por: Qi, Wenbo, et al.
Publicado: (2020)

Case report: recurrent metastatic breast cancer in internal mammary dissection bed discovered at the time of coronary bypass
por: Woodard, Gavitt A., et al.
Publicado: (2019)

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
por: Leprieur, Etienne Giroux, et al.
Publicado: (2016)

SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma
por: Zhang, Yi, et al.
Publicado: (2013)

Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma
por: Huo, Yansong, et al.
Publicado: (2022)

Integrated Multiomics Analyses Revealing Different Molecular Profiles Between Early- and Late-Stage Lung Adenocarcinoma
por: Yue, Dongsheng, et al.
Publicado: (2021)

Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer
por: Belaidi, Lahcene, et al.
Publicado: (2023)

Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to Cardiotoxicity
por: Li, Yue, et al.
Publicado: (2021)

FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid
por: Kang, Hio Chung, et al.
Publicado: (2016)

Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center
por: Zhu, Jianquan, et al.
Publicado: (2021)

A review of soft-tissue sarcomas: translation of biological advances into treatment measures
por: Hoang, Ngoc T, et al.
Publicado: (2018)

Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma
por: Yue, Dongsheng, et al.
Publicado: (2021)

Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration
por: Wang, Lei, et al.
Publicado: (2017)

Tumor‐associated macrophages (TAMs)‐derived osteopontin (OPN) upregulates PD‐L1 expression and predicts poor prognosis in non‐small cell lung cancer (NSCLC)
por: Li, Yue, et al.
Publicado: (2021)

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
por: Malapelle, Umberto, et al.
Publicado: (2021)

Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
por: Gopalakrishnan, Ramakrishnan, et al.
Publicado: (2015)

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
por: Tolani, Bhairavi, et al.
Publicado: (2013)

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing
por: Tang, Chao, et al.
Publicado: (2023)

The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm
por: Zhang, Hua, et al.
Publicado: (2021)

Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines
por: Yue, Dongsheng, et al.
Publicado: (2014)

CITED4 enhances the metastatic potential of lung adenocarcinoma
por: Zhang, Lianmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3d24hjimtm6ig4de220vm8psq5